ViroCell Biologics

📍 London, United Kingdom🗓 Founded 2020👥 67 employees💰 Last funded Aug 2022
Biotechnology Research🌐 virocell.com
Website LinkedIn
ViroCell Biologics is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in ViroCell Biologics?
ViroCell Biologics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did ViroCell Biologics last raise funding?
The most recent investment in ViroCell Biologics recorded on gritt.io was in August 2022.
When was ViroCell Biologics founded?
ViroCell Biologics was founded in 2020.
What industry is ViroCell Biologics in?
ViroCell Biologics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ViroCell Biologics based?
ViroCell Biologics is headquartered in London, United Kingdom.